Fulgent Genetics Inc reports results for the quarter ended in March - Earnings Summary

Fulgent Genetics

05/05/2023 14:32

* Fulgent Genetics Inc  FLGT.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 43 cents per share.
    * Revenue fell 79.3% to $66.17 million from a year ago;
analysts
expected $60.05 million. 
    * Fulgent Genetics Inc's reported EPS for the quarter was a
loss
of 52 cents​.
    * The mean earnings estimate of analysts had risen by
about 35.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Fulgent Genetics Inc shares had fallen by 8.6% this
quarter and
lost 4.2% so far this year.
    * The company reported a quarterly loss of $15.34 million.
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
5 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.43          -0.22          Beat
 Dec. 31 2022      -0.56          -0.48          Beat
 Sep. 30 2022      0.05           0.32           Beat
 Jun. 30 2022      0.73           0.78           Beat